196 related articles for article (PubMed ID: 20455003)
1. STAT3 tyrosine phosphorylation influences survival in glioblastoma.
Birner P; Toumangelova-Uzeir K; Natchev S; Guentchev M
J Neurooncol; 2010 Dec; 100(3):339-43. PubMed ID: 20455003
[TBL] [Abstract][Full Text] [Related]
2. The role of p-Stat3 Y705 immunohistochemistry in glioblastoma prognosis.
Susman S; Pîrlog R; Leucuța D; Mitre AO; Padurean VA; Melincovici C; Moldovan I; Crișan D; Florian SI
Diagn Pathol; 2019 Nov; 14(1):124. PubMed ID: 31690341
[TBL] [Abstract][Full Text] [Related]
3. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
[TBL] [Abstract][Full Text] [Related]
4. STAT3 serine 727 phosphorylation influences clinical outcome in glioblastoma.
Lin GS; Chen YP; Lin ZX; Wang XF; Zheng ZQ; Chen L
Int J Clin Exp Pathol; 2014; 7(6):3141-9. PubMed ID: 25031733
[TBL] [Abstract][Full Text] [Related]
5. Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity.
Kim HS; Li A; Ahn S; Song H; Zhang W
Sci Rep; 2014 Dec; 4():7330. PubMed ID: 25476455
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.
Ouédraogo ZG; Müller-Barthélémy M; Kemeny JL; Dedieu V; Biau J; Khalil T; Raoelfils LI; Granzotto A; Pereira B; Beaudoin C; Guissou IP; Berger M; Morel L; Chautard E; Verrelle P
Brain Pathol; 2016 Jan; 26(1):18-30. PubMed ID: 25736961
[TBL] [Abstract][Full Text] [Related]
7. STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX
Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192
[TBL] [Abstract][Full Text] [Related]
8. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
9. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.
de la Iglesia N; Konopka G; Puram SV; Chan JA; Bachoo RM; You MJ; Levy DE; Depinho RA; Bonni A
Genes Dev; 2008 Feb; 22(4):449-62. PubMed ID: 18258752
[TBL] [Abstract][Full Text] [Related]
10. Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.
Ouédraogo ZG; Biau J; Kemeny JL; Morel L; Verrelle P; Chautard E
Mol Neurobiol; 2017 Oct; 54(8):5780-5797. PubMed ID: 27660268
[TBL] [Abstract][Full Text] [Related]
11. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
13. DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome.
Televantou D; Karkavelas G; Hytiroglou P; Lampaki S; Iliadis G; Selviaridis P; Polyzoidis KS; Fountzilas G; Kotoula V
Pathol Oncol Res; 2013 Apr; 19(2):329-43. PubMed ID: 23250732
[TBL] [Abstract][Full Text] [Related]
14. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
15. The role of Stat3 in glioblastoma multiforme.
Luwor RB; Stylli SS; Kaye AH
J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
[TBL] [Abstract][Full Text] [Related]
16. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract][Full Text] [Related]
17. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.
Yang F; Brown C; Buettner R; Hedvat M; Starr R; Scuto A; Schroeder A; Jensen M; Jove R
Mol Cancer Ther; 2010 Apr; 9(4):953-62. PubMed ID: 20371721
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.
Senft C; Priester M; Polacin M; Schröder K; Seifert V; Kögel D; Weissenberger J
J Neurooncol; 2011 Feb; 101(3):393-403. PubMed ID: 20589525
[TBL] [Abstract][Full Text] [Related]
20. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
